Glenmark Therapeutics, Inc. 2023-07-26 Health serious FDA
Health · FDA · Recall #FDA-D-0939-2023
Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark… Recall
Issued July 26, 2023 · Glenmark Therapeutics, Inc.
In July 2023, Glenmark Therapeutics, Inc. recalled the Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.
What you should do
- 1 Stop using Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Glenmark Therapeutics, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Glenmark Therapeutics, Inc.
- Category
- Health
- Recall date
- July 26, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0939-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Glenmark Therapeutics, Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.